Sabin Vaccine Institute
- Public, NPO, govt., economic development
The Sabin Vaccine Institute, a non-profit global health organization, is seeking additional vaccine assets for development. Our focus is on developing vaccines against infectious diseases that disproportionally impact people living in low-and-middle-income countries and therefore are not likely to be commercially viable for a company. We are specifically interested in assets supported with strong preclinical and early clinical data. If your company has such an asset, but for business purposes it is not being developed further, please reach out. We will consider various business development models.
We are currently conducting Phase 2 clinical trials for monovalent vaccines against Marburg and Sudan Ebola on the cAd-3 platform. This program was in-licensed from GSK in 2019 and is supported by government funding.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}